Der neueste Peer-reviewed Artikel


    European Urology Focus
    E2F1 Signalling is Predictive of Chemoresistance and Lymphogenic Metastasis in Penile Cancer: A Pilot Functional Study Reveals New Prognostic Biomarkers.
    Fenner F, Goody D, Protzel C, Erbersdobler A, Richter C, Hartz JM, Naumann CM, Kalthoff H, Herchenröder O, Hakenberg OW, Pützer BM.

Der neueste Buchartikel


    Regenerative Medicine, Chapter 19, 2nd ed. 2013 (31. Januar 2013). G. Steinhoff. Textbook Regenerative Medicine – From Protocol to Patient. Springer-Verlag GmbH ISBN-10: 9400756895 ISBN-13: 9789400756892
    Vector technology and cell targeting: Peptide-tagged adenoviral vectors as a powerful tool for cell specific targeting.
    Reetz J, Herchenröder O, Schmidt A, Pützer BM.

Der neueste Abstract


    JEADV 2017; 31:61-62.
    Melanoma-associated hypopigmentation as sign of EMT-propelled metastatic spread: towards identification of the molecular particularities.
    Fürst K, Steder, M, Logotheti, S, Marquardt, S, Engelmann D, Pützer, BM.

Die neueste Abschlussarbeit


    Ferdinand Fenner (Arzt)
    Der Transkriptionsfaktor E2F1 in Peniskarzinomzellen
    Rostock 

... weitere Publikationen


    Clin Cancer Res. 2004; 10:626-633.
    Quantitative TP73 transcript analysis in hepatocellular carcinomas.
    Stiewe T, Tuve S, Peter M, Tannapfel A, Elmaagacli AH, Pützer BM.
    Viruses. 2014 Apr 2;6(4):1540-63.
    Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer.
    Reetz J, Herchenröder O, Pützer BM.
    Int J Cancer. 2016 Apr 1;138(7):1792-801.
    Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantation.
    Casalegno-Garduño R, Schmitt A, Spitschak A, Greiner J, Wang L, Hilgendorf I, Hirt C, Ho AD, Freund M, Schmitt M.